Upadacitinib in UC
Vedolizumab IV vs SC in UC
Mirikizumab in UC
2º antiTNF +/- Azathioprine in IBD patients who had immune mediated LOR to first antiTNF
Upadacitinib in CD
Pregnancy safety of antiTNF and vedolizumab
Cobitolimod in UC
Low FODMAP trial on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease
Mirikizumab phase 2 trial in UC
Etrasimod in UC